Mathilde Bouchet

Mathilde Bouchet

Auto-generated profile, based on publicly available information

Mathilde Bouchet

Institut de Génomique Fonctionnelle de Lyon, ENS de Lyon, CNRS, Université Lyon 1, Lyon 69007, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Cancer Research
Verified
Journal Article
Closed access
PDF file
MBMathilde Bouchet
Mathilde Bouchet
ALAlexandra Lainé
Alexandra Lainé
CBCyril Boyault
Cyril Boyault
MPMathilde Proponnet-Guerault
Mathilde Proponnet-Guerault
EMEmmanuelle Meugnier
Emmanuelle Meugnier
EBEdith Bonnelye
Edith Bonnelye
Bone is the most common metastatic site for breast cancer. Although the estrogen-related receptor alpha (ERRα) has been implicated in breast cancer cell dissemination to the bone from the primary tumor, its role after tumor cell anchorage in the bone microenvironment remains elusive. Here, we reveal that ERRα inhibits the progression of bone metastases of breast cancer cells by increasing the immune activity of the bone microenvironment. Overexpression of ERRα in breast cancer bone metastases induced expression of chemokines CCL17 and CCL20 and repressed production of TGFβ3. Subsequently, CD8+ T lymphocytes recruited to bone metastases escaped TGFβ signaling control and were endowed with exacerbated cytotoxic features, resulting in significant reduction in metastases. The clinical relevance of our findings in mice was confirmed in over 240 patients with breast cancer. Thus, this study reveals that ERRα regulates immune properties in the bone microenvironment that contributes to decreasing metastatic growth. Significance: This study places ERRα at the interplay between the immune response and bone metastases of breast cancer, highlighting a potential target for intervention in advanced disease.

3 July 2026 in Science Advances
Verified
Journal Article
Open access
CGCamille Guillermin
Camille Guillermin
VTViolaine Tribollet
Violaine Tribollet
MBMathilde Bouchet
Mathilde Bouchet
ALAnne Laurencon
Anne Laurencon
DZDan Zhou
Dan Zhou
JEJonathan Enriquez
Jonathan Enriquez
Skeletal muscles exhibit notable morphological diversity, yet the developmental mechanisms specifying distinct identities are unclear. Using Drosophila leg muscles, we show that naïve mesodermal precursors undergo stepwise specification orchestrated by epithelial morphogens. Wg/Wnt1 and Dpp/BMP first restrict multipotent precursors into proximal and distal lineages. Within the distal lineage, successive fate bifurcations generate distinct muscle subtypes and a separate nonmuscle lineage of neuronal lamella cells. Focusing on one lineage, we demonstrate that Wg and Dpp act again to control the spatiotemporal deployment of transcription factors, ensuring that groups of myoblasts destined to fuse to produce a specific muscle share a coordinated transcriptional identity. Thus, epithelial morphogens not only pattern the epithelium but also synchronize myoblast specification, enabling the emergence of diverse muscles from syncytial fibers. Our findings provide a framework for the developmental and evolutionary origins of appendicular muscles and may help explain the selective vulnerability of specific muscles in muscular dystrophies.

31 March 2023
Verified
Other
Open access
MBMathilde Bouchet
Mathilde Bouchet
ALAlexandra Lainé
Alexandra Lainé
CBCyril Boyault
Cyril Boyault
MPMathilde Proponnet-Guerault
Mathilde Proponnet-Guerault
EMEmmanuelle Meugnier
Emmanuelle Meugnier
EBEdith Bonnelye
Edith Bonnelye
Human and mouse primer sequences and PCR cycling and ChIP conditions used.

31 March 2023
Verified
Other
Open access
MBMathilde Bouchet
Mathilde Bouchet
ALAlexandra Lainé
Alexandra Lainé
CBCyril Boyault
Cyril Boyault
MPMathilde Proponnet-Guerault
Mathilde Proponnet-Guerault
EMEmmanuelle Meugnier
Emmanuelle Meugnier
EBEdith Bonnelye
Edith Bonnelye
Bone is the most common metastatic site for breast cancer. Although the estrogen-related receptor alpha (ERRα) has been implicated in breast cancer cell dissemination to the bone from the primary tumor, its role after tumor cell anchorage in the bone microenvironment remains elusive. Here, we reveal that ERRα inhibits the progression of bone metastases of breast cancer cells by increasing the immune activity of the bone microenvironment. Overexpression of ERRα in breast cancer bone metastases induced expression of chemokines CCL17 and CCL20 and repressed production of TGFβ3. Subsequently, CD8+ T lymphocytes recruited to bone metastases escaped TGFβ signaling control and were endowed with exacerbated cytotoxic features, resulting in significant reduction in metastases. The clinical relevance of our findings in mice was confirmed in over 240 patients with breast cancer. Thus, this study reveals that ERRα regulates immune properties in the bone microenvironment that contributes to decreasing metastatic growth.Significance:This study places ERRα at the interplay between the immune response and bone metastases of breast cancer, highlighting a potential target for intervention in advanced disease.

31 March 2023
Verified
Other
Open access
MBMathilde Bouchet
Mathilde Bouchet
ALAlexandra Lainé
Alexandra Lainé
CBCyril Boyault
Cyril Boyault
MPMathilde Proponnet-Guerault
Mathilde Proponnet-Guerault
EMEmmanuelle Meugnier
Emmanuelle Meugnier
EBEdith Bonnelye
Edith Bonnelye
"Minimal Network" of ESRRA, CCL17 and CCL20"

31 March 2023
Verified
Other
Open access
MBMathilde Bouchet
Mathilde Bouchet
ALAlexandra Lainé
Alexandra Lainé
CBCyril Boyault
Cyril Boyault
MPMathilde Proponnet-Guerault
Mathilde Proponnet-Guerault
EMEmmanuelle Meugnier
Emmanuelle Meugnier
EBEdith Bonnelye
Edith Bonnelye
Cytotoxic activity in the spleen and the lung and CD8+ T proliferation